For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:

https://www.mycme.com/courses/answering-questions-about-homozygous-familial-hypercholesterolemia-9140

Featuring faculty Zahid Ahmad, MD, FNLA, and Don Wilson, MD

Summary
Homozygous familial hypercholesterolemia (FH) is a rare but critical genetic disorder characterized by extremely high LDL cholesterol levels, significantly increasing the risk of early cardiovascular disease. In this activity, Dr. Zahid Ahmad and Dr. Don Wilson provide expert insights into homozygous FH, answering questions from recent live-virtual symposia. They cover crucial topics, including diagnosis, pediatric lipid screening, genetic testing, and care coordination. The experts emphasize the significance of specialized care and early intervention for individuals with homozygous FH, aiming to better inform healthcare professionals and improve patient outcomes.

Learning Objectives
Upon completion of this activity, learners should be able to: 

• Diagnose HoFH based on clinical criteria and genetic testing when indicated
• Implement, or refer patients for, cascade screening and the appropriate pharmacologic treatment of HoFH
• Recognize and address patient and family needs to overcome barriers to care in HoFH

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which include 0 hours of pharmacology).

Click on the link to view the summary of individual disclosures.
https://www.naceonline.com/courses/deep-dive-into-five-answering-your-questions-about-hofh

Disclosure of Commercial Support
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Please visit http://naceonline.com to engage in more live and on demand CME/CE content.